ロード中...
Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro
PURPOSE: Osteoarthritis (OA) is a prevalent, progressively degenerative disease. Researchers have rigorously documented clinical improvement in participants receiving prolotherapy for OA. The mechanism of action is unknown; therefore, basic science studies are required. One hypothesized mechanism is...
保存先:
| 出版年: | J Exp Orthop |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7719583/ https://ncbi.nlm.nih.gov/pubmed/33280075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40634-020-00312-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|